• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » CMR Surgical, Nvidia showcase predictive surgical robotic capabilities

CMR Surgical, Nvidia showcase predictive surgical robotic capabilities

July 22, 2026 By Sean Whooley

This is a CMR Surgical marketing image of its Versius Plus surgical robotics system.
The Versius Plus surgical robotics system [Image courtesy of CMR Surgical]
CMR Surgical is today showcasing a the capabilities of its Versius Plus surgical robot in a simulated environment with Nvidia technology.

The Cambridge, UK-based company is demonstrating what it labels as a “new paradigm of simulation in surgical robotics at” at SRS 2026. It said the demonstration shows Versius Plus when trained to learn from clinical experience to predict how the future surgical environment could evolve under different actions.

Versius became the first multi-port, soft tissue general robotic-assisted surgical device to gain clearance through the FDA’s de novo process in 2024. CMR added FDA clearance for its next-generation Versius Plus system in cholecystectomy in December 2025.

CMR Surgical’s technology leverages Nvidia’s Isaac for Healthcare’s Medical Physics Simulation, Cosmos-H-Dreams. This shows how the system could help guide surgeon decision-making and potentially improve patient outcomes. Last fall, the company became an early adopter of Nvidia’s IGX Thor platform for surgical robotics. Earlier this year, it announced a new effort with Nvidia to train the next generation of intelligent surgical systems.

Leveraging Versius Plus, CMR Surgical said the new capabilities make it the largest contributor to Open-H Embodiment, the world’s largest open dataset for healthcare robotics.

Cosmos-H-Dreams real-time simulation is fine-tuned for Versius Plus using Open-H-Embodiment open data along with the Cosmos world foundation model. This action-conditioned model, built on Nvidia’s physical AI infrastructure, takes the current surgical scene along with a proposed action by the robot. It then predicts what the operating field could look like after that action.

Commentary from CMR Surgical and Nvidia officials

Chris Fryer, chief technology officer at CMR Surgical said:

“Versius Plus gives us the foundation to explore the next generation of intelligent surgical systems. Today, surgical robots are tools in the operating room. Our vision is to build on global surgical data to create systems that can provide surgeons with deeper insight, help anticipate future scenarios and support better-informed decision making. This simulation is an important step towards that future.”

David Niewolny, Head of Business Development for Healthcare and Medical Technology at NVIDIA, said:

“True surgical intelligence requires the ability to learn and adapt. By combining NVIDIA Isaac for Healthcare Medical Physics Simulation to CMR’s rich clinical insights, developers can create virtual training environments that mirror the complexity of human anatomy. This enables developers to generate diverse surgical scenarios and evaluate robotic behaviour at scale, accelerating the path toward more intelligent surgical robotics.”

Filed Under: Artificial Intelligence (AI), Featured, Health Technology, Machine Learning (ML), Robotic-Assisted, Surgical, Surgical Robotics Tagged With: CMR Surgical, nvidia, SRS 2026

More recent news

  • Former Shockwave Medical CEO joins Solenic Medical’s board
  • Anaconda Biomed brings in $56 million
  • Precision Neuroscience raises $250M in Series D for its BCI
  • Fresenius discontinuing Chinese sales of 4008A hemodialysis system
  • Perfuze’s super-bore stroke catheter tops conventional, cyclic aspiration in bench study

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy